NasdaqCM - Nasdaq Real Time Price USD
INmune Bio, Inc. (INMB)
As of 9:31 AM EST. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
57,001.00
81,795.00
99,945.00
40,656.00
Total Liabilities Net Minority Interest
18,862.00
21,691.00
19,720.00
1,902.00
Total Equity Gross Minority Interest
38,139.00
60,104.00
80,225.00
38,754.00
Total Capitalization
38,139.00
69,801.00
94,683.00
38,754.00
Common Stock Equity
38,139.00
60,104.00
80,225.00
38,754.00
Capital Lease Obligations
516.00
613.00
776.00
160.00
Net Tangible Assets
21,625.00
43,590.00
63,711.00
22,240.00
Working Capital
21,477.00
53,757.00
78,247.00
22,210.00
Invested Capital
48,060.00
74,801.00
94,683.00
38,754.00
Tangible Book Value
21,625.00
43,590.00
63,711.00
22,240.00
Total Debt
10,437.00
15,310.00
15,234.00
160.00
Share Issued
17,950.78
17,946.00
17,843.30
13,481.28
Ordinary Shares Number
17,950.78
17,946.00
17,843.30
13,481.28
12/31/2020 - 2/4/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TFFP TFF Pharmaceuticals, Inc.
1.7650
+8.34%
COYA Coya Therapeutics, Inc.
7.34
+1.67%
ANIX Anixa Biosciences, Inc.
3.6282
+0.23%
ANVS Annovis Bio, Inc.
8.70
+1.05%
GANX Gain Therapeutics, Inc.
2.2563
+1.18%
IMUX Immunic, Inc.
1.1817
+0.14%
VTGN Vistagen Therapeutics, Inc.
3.1732
+1.68%
INAB IN8bio, Inc.
0.3300
-0.18%
CUE Cue Biopharma, Inc.
1.7500
-1.69%
TERN Terns Pharmaceuticals, Inc.
7.03
-0.42%